Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AL Amyloidosis (AL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01408225
What this trial is testing

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

Who this might be right for
Plasma Cell DyscrasiasMonoclonal Gammopathy of Undetermined SignificanceAL Amyloidosis+1 more
Ohio State University Comprehensive Cancer Center 5,000
Testing effectiveness (Phase 2)Study completedNCT00981708
What this trial is testing

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

Who this might be right for
Amyloidosis
University of Athens 37
Testing effectiveness (Phase 2)Ended earlyNCT00075608
What this trial is testing

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Boston Medical Center 12
Not applicableLooking for participantsNCT07172243
What this trial is testing

BE.Amycon Biobank & Data Registry UZ Leuven

Who this might be right for
AmyloidosisAL AmyloidosisAmyloidosis Cardiac
Universitaire Ziekenhuizen KU Leuven 505
Testing effectiveness (Phase 2)Active Not RecruitingNCT03315026
What this trial is testing

Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis

Who this might be right for
Multiple MyelomaAL Amyloidosis
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01511263
What this trial is testing

Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis

Who this might be right for
Primary Amyloidosis of Light Chain Type
Fondazione IRCCS Policlinico San Matteo di Pavia 86
Not applicableStudy completedNCT02555969
What this trial is testing

Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis

Who this might be right for
AmyloidosisPrimary Amyloidosis
Tufts Medical Center 56
Not applicableNot Yet RecruitingNCT07624760
What this trial is testing

Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging

Who this might be right for
Monoclonal GammopathyMonoclonal Gammopathy of Undetermined Significance (MGUS)Multiple Myeloma+2 more
University of Zurich 50
Not applicableLooking for participantsNCT06365060
What this trial is testing

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Tufts Medical Center 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055724
What this trial is testing

Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis

Who this might be right for
AL Amyloidosis
Nanjing IASO Biotechnology Co., Ltd. 17
Testing effectiveness (Phase 2)Study completedNCT01222260
What this trial is testing

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

Who this might be right for
AL Amyloidosis
Columbia University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05898646
What this trial is testing

Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

Who this might be right for
AL Amyloidosis
Mayo Clinic 96
Testing effectiveness (Phase 2)Study completedNCT02207556
What this trial is testing

Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial

Who this might be right for
Primary Systemic Amyloidosis
Medical College of Wisconsin 32
Early research (Phase 1)Study completedNCT03283917
What this trial is testing

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Who this might be right for
Newly Diagnosed Primary AmyloidosisRecurrent Primary AmyloidosisRefractory Primary Amyloidosis
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT05235269
What this trial is testing

Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis

Who this might be right for
Amyloidosis
Attralus, Inc. 33
Early research (Phase 1)Looking for participantsNCT07250269
What this trial is testing

Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis

Who this might be right for
Relapsed/Refractory AL Amyloidosis
Gracell Biotechnologies (Shanghai) Co., Ltd. 9
Testing effectiveness (Phase 2)Looking for participantsNCT06292780
What this trial is testing

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Who this might be right for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Regeneron Pharmaceuticals 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996406
What this trial is testing

Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14)

Who this might be right for
Light Chain (AL) AmyloidosisCCND1 TranslocationVenetoclax
Peking Union Medical College Hospital 36
Early research (Phase 1)Ended earlyNCT01728259
What this trial is testing

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
Barbara Ann Karmanos Cancer Institute 18
Not applicableStudy completedNCT04615572
What this trial is testing

Screening to Improve Survival in AL Amyloidosis

Who this might be right for
Smoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Tufts Medical Center 35
Next Page